Unlocking Safe Ibogaine Care
In this Delphi Insight Session, Lia Mix shares her journey with trauma and healing, and how Delphi and IHPI are advancing Ibogaine therapy.
Insight Sessions
Tracking Real World Psychedelic Use Nationwide
Kate Reynolds from Rocky Mountain Poison and Drug Safety (RPMDS) discusses how NSIHT tracks real world psychedelic use nationwide.
Psychedelics and Reimbursement in Europe
Join Lia Mix, CEO of Delphi, and Floris Wolswijk, Senior Policy and Research Partner at Delphi, for the third Delphi Insight Session on reimbursement pathways for psychedelic therapies in Europe.
Conversation with Tyler Norris
The second Delphi Insight Session features a conversation with Tyler Norris on the integration of psychedelics into the broader healthcare system, the challenges, and roadmap towards making this integration happen.
Delphi’s Strategic Outlook
The first Delphi Insight Session – an introduction to Delphi, our work, and our vision for an integrated future.
